1.Optimization of bone removal ratio for dual-energy cerebral subtraction angiography with Flash dual-source CT
Jianming WANG ; Jun MAO ; Haidong CHEN ; Wanhong XIAO ; Min CHEN ; Geying ZHANG
Journal of Practical Radiology 2017;33(8):1248-1251
Objective To evaluate the clinical application of regulating bone removal ratio in dual-energy cerebral subtraction angiography.Methods A total of 45 patients who underwent two phases dual-energy CT angiography (CTA) were recruited and divided into several groups by the value of bone removal ratio,as follows: group A (Ratio=1.6), group B (Ratio=1.7), group C (Ratio=1.8) and group D (Ratio=1.9,default), as well as group E (100kV Neuro-DSA).The image quality of dual-energy CTA was evaluated by double blind method according to bone suppression and integrity of the vessel lumen (1-5 points, 1=poor, 5=excellent, 3-5=satisfactory).The bone removal ratio dependence of the image quality was analyzed using the self-control method.Moreover,the signal-to-noise ratio (SNR),contrast-to-noise ratio (CNR) and image scores were compared with the Neuro-DSA subtraction among these groups.Results The overall satisfaction of basis cranii images that were executed by dual-energy CTA with different bone removal ratios was listed as below: group A 73.33%, group B 91.11%, group C 78.52%, group D 70.37%.The satisfaction of siphon segment and petrous segment reached the maximum when the value of ratio was 1.7,and with significantly difference (P<0.05).The SNR and CNR were not significantly different among group B, group D, and group E (P>0.05).Conclusion With optimal bone removal ratio,the single enhanced dual-energy subtraction image quality with flash dual-source CT is consistent well with that of conventional 100 kV Neuro-DSA subtraction.Thus,this method is recommended in clinical emergency cerebrovascular examination for the improved image quality,which can compensate the shortage of vascular defect in basis cranill.
2.Clinical study of target fibrinogen level treated by Batroxobin in patients with acute cerebral infarction
Geying WANG ; Fangling WU ; Lin JIANG
Journal of Clinical Neurology 1995;0(04):-
130 mg/dl). Conclusions The fibrinogen level may reduce to 40~130 mg/dl treated with Batroxobin in patients with acute cerebral infarct, but whether it could be regarded as a target level need more studies.

Result Analysis
Print
Save
E-mail